On November 12, 2025, the 93rd API China grandly opened at the Chongqing International Expo Center. As a pivotal annual event in the global pharmaceutical industry, API China has rooted itself in the Chinese pharmaceutical market for over 40 years and evolved into a core platform for global pharmaceutical brands to explore the Chinese market. Sichuan Xieli Pharmaceutical Co., Ltd. showcased its flagship products at the expo, demonstrating the strength of Chinese API enterprises to the world.

A Buzzing Booth; The Center of Attention

Inside the exhibition hall, Xieli’s booth attracted a constant stream of visitors. Its neat and elegant display design, eye-catching wall of international certification certificates, and a diverse array of star products drew global customers to stop and engage.

Mr. Zhang Qiang, Chairman of the Board, led a 20-strong team consisting of key members from domestic sales, international trade, R&D, quality unit, registration, and BD departments. The team wasted no time in conducting in-depth face-to-face exchanges with customers. After learning about the company’s bile acid products, one customer commented sincerely, “The quality is outstanding, the supply is stable, and the full-process traceability system gives us complete confidence in our cooperation!” This recognition stands as the best reward for Xieli’s long-standing commitment to “quality first.”

A Comprehensive Product Portfolio with Standout Varieties

At the expo, Xieli presented a diverse product portfolio covering multiple categories of natural products and specialty APIs, fully reflecting the company’s diversified layout and technological accumulation.

Flavonoids: Diosmin, Hesperidin, Rutin, and Troxerutin – classic representatives of natural plant extracts, widely used in addressing varicose veins, capillary fragility, and improving microcirculation;

Alkaloids: Cytisine, gaining momentum in neurological disease research and favored by research institutions and pharmaceutical enterprises alike;

Bile Acids: Ursodeoxycholic Acid, a well-established drug for treating cholestasis and gallstones, enjoys high market recognition and stable demand;

Oncology: Capecitabine and Irinotecan highlights Xieli’s capabilities in the field of high-end chemical APIs.

From natural plant extracts to high-end synthetic products, the extensive product range meets the diverse needs of the global market and embodies the company’s development strategy of “horizontal expansion and vertical deepening”.

In-depth Communication, Yield Fruitful Results

During the expo, Xieli team worked in an orderly and efficient manner:

Held multiple closed-door discussions with long-term strategic partners from around the world, reaching consensus on topics such as product quality upgrading, green production processes, and supply chain optimization;

Actively engaged with potential customers from emerging markets, exploring the application of natural products in cardiovascular, digestive, and oncology fields.

“International certification system + stable delivery capacity” has become the core reason for customers to choose long-term cooperation, with a steady flow of intentional partnerships secured on-site.

Technology-Driven, Toward a Green Future

Innovation is the core driver of development! During the expo, the company’s R&D team conducted in-depth discussions with multiple equipment suppliers, exploring green extraction technologies and their application in industrial production – such as how to maintain high-purity extraction while reducing energy consumption, and how to achieve more eco-friendly solvent recovery. These topics, which are crucial to enterprise upgrading and the sustainable development of the industry, became the focus of their exchanges.

Meanwhile, the team also discussed “the potential application of plant extracts in new drug R&D” with several international pharmaceutical companies. Both parties agreed that natural products will continue to hold broad prospects in the future pharmaceutical field, and further development combined with modern technology is bound to bring more breakthrough achievements.

We sincerely invite global partners to join hands with us. Guided by the concept of “Plant Extraction Technology,” and relying on solid R&D and production capabilities, we will jointly explore the boundless possibilities of plant extracts and specialty APIs in the pharmaceutical and healthcare fields, contribute more “Chinese wisdom” to the global pharmaceutical industry, and create a healthier and better future together!